PRENETICS GLOBAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.19 USD | +1.27% |
|
-16.44% | -46.02% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Prenetics Global Ltd is a company mainly engaged in the diagnostics and genetic testing business. The Company operates its business through two segments. The Diagnostics segment is engaged in the provision of COVID-19 testing services and operation testing laboratories. The Segment is also engaged in the development of health monitoring systems. The Prevention segment is engaged in the provision of genetics testing services to individuals and corporate entities.
Calendar
2024-06-02
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.19
USD
Average target price
9
USD
Spread / Average Target
+182.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -46.02% | 38.34M | |
| -14.19% | 11.52B | |
| +44.16% | 3.27B | |
| -19.90% | 2.02B | |
| -38.37% | 2.03B | |
| -30.21% | 1.44B | |
| +16.18% | 1.01B | |
| -6.11% | 719M | |
| -32.75% | 418M | |
| -52.35% | 339M |
- Stock Market
- Equities
- PRE Stock
- News Prenetics Global Limited
- Investors Cautious Ahead of Powell Speech, Weighing on US Equity Futures
